Realeaf Botanicals

In August 2026, Realeaf Botanicals concentrated 85.02% of sales in Vapor Pens, where category sales grew 56.34% year over year and 31.55% month over month, while the brand’s average price fell 43.77% year over year, indicating a volume-led expansion. Edible lifted share to 7.72% on 643.21% year-over-year growth and 36.02% month-over-month, contrasting with Pre-Roll at 3.89% share that declined 14.99% year over year despite a 59.11% month-over-month uptick, and with Concentrates at 1.01% share contracting 17.47% year over year and 30.15% month over month. Flower’s 1.85% share slid 54.57% month over month with no year-over-year basis, while Topical, at 0.17% share, spiked 80.70% month over month despite a 45.06% year-over-year decline. The pattern implies the brand is leaning into high-velocity, price-accessible formats to drive unit growth, with Vapor Pens anchoring scale and Edible acting as the incremental growth wedge.

With Vapor Pens at rank 14 in Illinois and holding 85.02% mix, the 31.55% month-over-month surge alongside a 43.77% price drop year over year implies a deliberate trade-down strategy aimed at gaining shelf turns and velocity within the segment. The 643.21% year-over-year lift in Edible against a 36.02% month-over-month gain, paired with Pre-Roll’s 14.99% year-over-year decline despite a 59.11% monthly bounce, suggests the portfolio is reallocating demand from combustion to ingestibles as a secondary pillar while trimming exposure in lagging, higher-friction segments like Concentrates (down 30.15% month over month) and Flower (down 54.57% month over month). The pattern implies Realeaf Botanicals is positioning as a value-forward inhalable leader with a growing edible adjunct, prioritizing price-elastic, repeat-purchase categories over niche potency formats.